Insulin Pricing MDL Sought By 5 States For Drug Makers, PBMs

Mealey's (May 26, 2023, 5:51 PM EDT) -- WASHINGTON, D.C. — Five states have asked the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize five federal lawsuits alleging that the three largest manufacturers of insulin and the three largest pharmacy benefit managers (PBMs) schemed to monopolize the market and to artificially inflate the cost of the diabetes hormone....

Attached Documents

Related Sections